Abstract
Acquisition of resistance, aggressiveness and immune evasion are limiting factors to the effectiveness of melanoma therapy. Thus, identifying a new candidate with therapeutic potential, as well as the definition of its molecular mechanism of action may contribute to the development of more efficient therapy protocols that could provide a better quality of life for the patients. We have re…